Kristina Lend

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;:ard-2024-226024

Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial

Lend K; Lampa J; Padyukov L; Hetland ML; Heiberg MS; Nordstrom DC; Nurmohamed MT; Rudin A; Ostergaard M; Haavardsholm EA; Horslev-Petersen K; Uhlig T; Sokka-Isler T; Gudbjornsson B; Grondal G; Frazzei G; Christiaans J; Wolbink G; Rispens T; Twisk JWR; van Vollenhoven RF
Article: RMD OPEN. 2024;10(2):e004227

Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study

Dubovyk V; Vasileiadis GK; Fatima T; Zhang Y; Kapetanovic MC; Kastbom A; Rizk M; Soederbergh A; Zhao SS; van Vollenhoven RF; Hetland ML; Haavardsholm EA; Nordstrom D; Nurmohamed MT; Gudbjornsson B; Lampa J; Ostergaard M; Heiberg MS; Sokka-Isler T; Grondal G; Lend K; Horslev-Petersen K; Uhlig T; Rudin A; Maglio C
Article: ARTHRITIS RESEARCH & THERAPY. 2024;26(1):61

Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis

Liu J; Idborg H; Korotkova M; Lend K; van Vollenhoven R; Lampa J; Rudin A; Nordstrom D; Gudbjornsson B; Grondal G; Uhlig T; Horslev-Petersen K; Merete HL; Ostergaard M; Nurmohamed M; Jakobsson P-J
Article: ARTHRITIS & RHEUMATOLOGY. 2024;76(3):363-376

Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial

Lend K; Koopman FA; Lampa J; Jansen G; Hetland ML; Uhlig T; Nordstroem D; Nurmohamed M; Gudbjornsson B; Rudin A; Ostergaard M; Heiberg MS; Sokka-Isler T; Horslev-Petersen K; Haavardsholm EA; Grondal G; Twisk JWR; van Vollenhoven R
Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(10):1286-1295

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

Ostergaard M; van Vollenhoven RF; Rudin A; Hetland ML; Heiberg MS; Nordstrom DC; Nurmohamed MT; Gudbjornsson B; Ornbjerg LM; Boyesen P; Lend K; Horslev-Petersen K; Uhlig T; Sokka T; Grondal G; Krabbe S; Lindqvist J; Gjertsson I; Glinatsi D; Kapetanovic MC; Aga A-B; Faustini F; Parmanne P; Lorenzen T; Giovanni C; Back J; Hendricks O; Vedder D; Rannio T; Grenholm E; Ljosa MK; Brodin E; Lindegaard H; Soderbergh A; Rizk M; Kastbom A; Larsson P; Uhrenholt L; Just SA; Stevens DJ; Laurbjerg TB; Bakland G; Olsen IC; Haavardsholm EA; Lampa J
Article: LANCET RHEUMATOLOGY. 2022;4(10):E688-E698

Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial

Lend K; van Vollenhoven RF; Lampa J; Hetland ML; Haavardsholm EA; Nordstrom D; Nurmohamed M; Gudbjornsson B; Rudin A; Ostergaard M; Uhlig T; Grondal G; Horslev-Petersen K; Heiberg MS; Sokka-Isler T; Koopman FA; Twisk JWR; Van der Horst-Bruinsma I
Article: BMJ-BRITISH MEDICAL JOURNAL. 2020;371:m4328

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial

Hetland ML; Haavardsholm EA; Rudin A; Nordstrom D; Nurmohamed M; Gudbjornsson B; Lampa J; Horslev-Petersen K; Uhlig T; Grondal G; Ostergaard M; Heiberg MS; Twisk J; Lend K; Krabbe S; Hyldstrup LH; Lindqvist J; Ekwall A-KH; Gron KL; Kapetanovic M; Faustini F; Tuompo R; Lorenzen T; Cagnotto G; Baecklund E; Hendricks O; Vedder D; Sokka-Isler T; Husmark T; Ljosa M-KA; Brodin E; Ellingsen T; Soderbergh A; Rizk M; Olsson AR; Larsson P; Uhrenholt L; Just SA; Stevens DJ; Laurberg TB; Bakland G; Olsen IC; van Vollenhoven R

Alla övriga publikationer

Conference publication: 2024;:85-86

OP0104 RHEUMATOID FACTOR, ANTI-CITRULLINATED PEPTIDE ANTIBODIES, AND SHARED EPITOPE AS PREDICTORS OF CLINICAL RESPONSE TO TREATMENT IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: A STUDY BASED ON A RANDOMIZED CONTROLLED TRIAL (NORD-STAR)

Lend K; Wolbink G; Rispens T; Padyukov L; Frazzei G; Christiaans J; Lampa J; Lund Hetland M; Heiberg MS; Nordström D; Nurmohamed M; Rudin A; Østergaard M; Haavardsholm EA; Hørslev-Petersen K; Uhlig T; Gudbjornsson B; Grondal G; Twisk JWR; Van Vollenhoven RF
Conference publication: 2024;:1670.1-161671

AB0758 CIRCULATING ADIPOKINES AND RESPONSE TO TREATMENT IN EARLY RHEUMATOID ARTHRITIS – DATA FROM THE RANDOMIZED NORD-STAR TRIAL

Vasileiadis GK; Zhang Y; Fatima T; Van Vollenhoven RF; Lampa J; Gudbjornsson B; Nordström D; Grondal G; Hørslev-Petersen K; Lend K; Heiberg MS; Lund Hetland M; Nurmohamed M; Uhlig T; Sokka-Isler T; Rudin A; Maglio C
Conference publication: 2024;:739-740

POS0724 SERUM METABOLOMICS PROFILING IDENTIFIES POTENTIAL BIOMARKERS FOR DISEASE ACTIVITY AND RESPONSE TO TREATMENT IN EARLY RHEUMATOID ARTHRITIS - A NORD-STAR SPIN-OFF STUDY

Fatima T; Vasileiadis GK; Van Vollenhoven RF; Lampa J; Gudbjornsson B; Haavardsholm EA; Nordström D; Grondal G; Hørslev-Petersen K; Lend K; Heiberg MS; Lund Hetland M; Nurmohamed M; Østergaard M; Uhlig T; Sokka-Isler T; Rudin A; Zhang Y; Maglio C
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:407-408

OBESITY IS A RISK FACTOR FOR POOR RESPONSE TO TREATMENT IN EARLY RHEUMATOID ARTHRITIS A NORD-STAR SPIN-OFF STUDY

Dubovyk V; Grondal G; Gudbjornsson B; Haavardsholm EA; Heiberg M; Hetland ML; Horslev-Petersen K; Kapetanovic MC; Kastbom A; Lampa J; Lend K; Nordstrom D; Nurmohamed M; Rizk M; Soderbergh A; Uhlig T; Ostergaard M; Van Vollenhoven R; Rudin A; Maglio C
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:591-592

TARGETING NET FORMATION IN EARLY RA PATIENTS; A SPIN-OFF STUDY FROM THE NORD-STAR

Dijkshoorn B; Wang T; Vedder D; Rudin A; Nordstrom D; Gudbjornsson B; Lend K; Uhlig T; Haavardsholm EA; Hetland ML; Heiberg M; Ostergaard M; Horslev-Petersen K; Lampa J; Van Vollenhoven R; Sokka-Isler T; Lood C; Nurmohamed M
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2023;75:752-754

Targeting NET Formation in Early RA Patients; A Spin-off Study from the NORD-STAR

Dijkshoorn B; Wang T; Grondal GM; Vedder D; Rudin A; Nordstrom D; Gudbjornsson B; Lend K; Uhlig T; Haavardsholm E; Hetland ML; Heiberg MS; Ostergaard M; Horslev-Petersen K; Lampa J; van Vollenhoven R; Lood C; Nurmohamed M
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2023;75:790-791

Obesity Is a Risk Factor for Poor Response to Treatment in Early Rheumatoid Arthritis - a NORD-STAR Spin-Off Study

Dubovyk V; Grondal GM; Gudbjornsson B; Haavardsholm EA; Heiberg MS; Hetland M; Horslev-Petersen K; Kapetanovic M; Kastbom A; Lampa J; Lend K; Nordstrom D; Nurmohamed M; Rizk M; Soderbergh A; Uhlig T; Ostergaard M; van Vollenhoven R; Rudin A; Maglio C
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:38-40

CERTOLIZUMAB-PEGOL, ABATACEPT, TOCILIZUMAB OR ACTIVE CONVENTIONALTHERAPY IN EARLY RHEUMATOID ARTHRITIS: CLINICAL AND RADIOGRAPHIC 48-WEEKS RESULTS OF THE INVESTIGATOR-INITIATED RANDOMIZED NORD-STARTRIAL

Ostergaard M; Van Vollenhoven R; Rudin A; Hetland ML; Heiberg M; Nordstrom D; Nurmohamed M; Gudbjornsson B; Ornbjerg LM; Boyesen P; Olsen I; Lend K; Horslev-Petersen K; Uhlig T; Sokka-Isler T; Grondal G; Krabbe S; Lindqvist J; Gjertsson I; Glinatsi D; Kapetanovic MC; Aga AB; Faustini F; Parmanne P; Lorenzen T; Cagnotto G; Back J; Hendricks O; Vedder D; Rannio T; Grenholm E; Lindegaard HM; Ljosa MKA; Brodin E; Soderbergh A; Rizk M; Hermansson E; Uhrenholt L; Larsson P; Just SA; Bakland G; Stevens D; Laurberg TB; Haavardsholm EA; Lampa J
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:515

PLASMA CALPROTECTIN WAS ASSESSED IN MULTIPLE BIOLOGICAL TREATMENT STRATEGIES FOR EARLY RHEUMATOID ARTHRITIS

Stevens D; Heiberg M; Kazemi A; Van Vollenhoven R; Lampa J; Rudin A; Lend K; Hetland ML; Ostergaard M; Nurmohamed M; Horslev-Petersen K; Nordstrom D; Gudbjornsson B; Uhlig T; Haavardsholm EA; Hammer HB
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:40-41

PROFOUND ANTICOAGULANT EFFECTS OF INITIAL ANTIRHEUMATIC TREATMENTS IN EARLY RHEUMATOID ARTHRITIS PATIENTS: A NORD-STAR SPIN-OFF STUDY

Dijkshoorn B; Antovic A; Vedder D; Rudin A; Nordstrom D; Gudbjornsson B; Lend K; Uhlig T; Haavardsholm EA; Grondal G; Hetland ML; Heiberg M; Ostergaard M; Horslev-Petersen K; Lampa J; Van Vollenhoven R; Nurmohamed M
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:3183-3185

Profound Anticoagulant Effects of Initial Antirheumatic Treatments in Early Rheumatoid Arthritis Patients; A NORD-STAR Spin-off Study

Dijkshoorn B; Vedder D; Rudin A; Nordstrom D; Gudbjornsson B; Lend K; Uhlig T; Haavardsholm E; Grondal GM; Hetland ML; Heiberg M; Ostergaard M; Horslev-Petersen K; Lampa J; van Vollenhoven R; Antovic A; Nurmohamed M
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2021;73:1701-1705

An Investigator-initiated Multicenter Randomized Study in Early Rheumatoid Arthritis of Active Conventional Therapy versus Three Biological Treatments: 48 Week Clinical and Radiographic Results of the NORD-STAR Trial

Ostergaard M; van Vollenhoven R; Rudin A; Hetland M; Heiberg MS; Nordstrom D; Nurmohamed M; Gudbjornsson B; Ornbjerg L; Boyesen P; Olsen I; Lend K; Horslev-Petersen K; Uhlig T; Sokka-Isler T; Grondal G; Krabbe S; Lindqvist J; Gjertsson I; Glinatsi D; Kapetanovic M; Aga A-B; Faustini F; Parmanne P; Lorenzen T; Giovanni C; Back J; Hendricks O; Vedder D; Rannio T; Grenholm E; Ljosa MK; Brodin E; Lindegaard HM; Soderbergh A; Rizk M; Hermansson E; Larsson P; Uhrenholt L; Just SA; Stevens DJ; Laurberg TB; Bakland G; Haavardsholm E; Lampa J
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2021;73:2565-2568

Sex Differences in Treatment Response to Three Different Biological Treatments and Corticosteroids in Patients with Early Rheumatoid Arthritis

Lend K; Van Vollenhoven RF; Lampa J; Hetland M; Haavardsholm E; Nordstrom D; Nurmohamed M; Gudbjornsson B; Rudin A; Ostergaard M; Uhlig T; Grondal G; Horslev-Petersen K; Heiberg MS; Sokka-Isler T; Twisk J; Van der Horst-Bruinsma I
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:13-14

A MULTICENTER RANDOMIZED STUDY IN EARLY RHEUMATOID ARTHRITIS TO COMPARE ACTIVE CONVENTIONAL THERAPY VERSUS THREE BIOLOGICAL TREATMENTS: 24 WEEK EFFICACY RESULTS OF THE NORD-STAR TRIAL

Hetland ML; Haavardsholm EA; Rudin A; Nordstrom D; Nurmohamed M; Gudbjornsson B; Lampa J; Horslev-Petersen K; Uhlig T; Grondal G; Ostergaard M; Heiberg M; Twisk J; Krabbe S; Lend K; Olsen I; Lindqvist J; Ekwall AKH; Gron KL; Kapetanovic C; Faustini F; Tuompo R; Lorenzen T; Cagnotto G; Baecklund E; Hendricks O; Vedder D; Sokka-Isler T; Husmark T; Ljosa MKA; Brodin E; Ellingsen T; Soderbergh A; Rizk M; Reckner A; Larsson P; Uhrenholt L; Just SA; Stevens D; Laurberg TB; Bakland G; Van Vollenhoven R
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2019;71

A Multicenter Randomized Study in Early Rheumatoid Arthritis to Compare Active Conventional Therapy versus Three Biological Treatments: 24 Week Efficacy and Safety Results of the NORD-STAR Trial

Hetland ML; Haavardsholm EA; Rudin A; Nordstrom D; Nurmohamed M; Gudbjornsson B; Lampa J; Horslev-Petersen K; Uhlig T; Grondal G; Ostergaard M; Heiberg M; Twisk J; Lend K; Krabbe S; Lindqvist J; Ekwall A-K; Gron KL; Kapetanovic M; Faustini F; Tuompo R; Lorenzen T; Cagnotto G; Baecklund E; Hendricks O; Vedder D; Sokka-isler T; Husmark T; Ljosa M-KA; Brodin E; Ellingsen T; Soderbergh A; Rizk M; Reckner A; Uhrenholt L; Larsson P; Just S; Stevens D; Laurberg T; Bakland G; Olsen IC; van Vollenhoven R
Review: RECOMBINANT PROTEIN EXPRESSION: PROKARYOTIC HOSTS AND CELL-FREE SYSTEMS. 2013;525:327-350

Finding Ciliary Genes: A Computational Approach

Henriksson J; Piasecki BP; Lend K; Burglin TR; Swoboda P

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI